1-12 of 12
Lara Mussolin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD20-Negative Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphomas and Mature B-Cell Leukemia in Children, Adolescent and Young Adults: A Retrospective Review

Luciana Vinti, Jolanda Pianese, Elisa Carraro, Paola Muggeo, Daniela Onofrillo, Irene d'Alba, Elisabetta Schiavello, Raffaella De Santis, Concetta Micalizzi, Veronica Barat, Katia Perruccio, Luca Lo Nigro, Barbara Buldini, Lara Mussolin, Valentina Bertaina, Rita de Vito, Marta Pillon, Franco Locatelli
Journal: Blood
Blood (2024) 144 (Supplement 1): 3086.
https://doi.org/10.1182/blood-2024-208728
Published: 2024
Journal Articles

Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors: 5-Year Update of a Phase 2 Open Label Monocentric Study

Federica Colombo, Andrea Aroldi, Stefano Crippa, Federica Cocito, Luca Guerra, Lavinia Monaco, Bianca Maria Granelli, Lara Mussolin, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2024) 144 (Supplement 1): 3117.
https://doi.org/10.1182/blood-2024-206041
Published: 2024
Journal Articles

Preliminary Results of Phase 2 Open Label Study of Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors

Alessia Ripamonti, Andrea Aroldi, Federica Cocito, Luca Guerra, Lavinia Monaco, Bianca Maria Granelli, Lara Mussolin, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2023) 142 (Supplement 1): 4474.
https://doi.org/10.1182/blood-2023-186702
Published: 2023
Journal Articles

Plasma S-Evs Mirnas in Pediatric B Lineage Leukemia: Transforming Factors of Bone Marrow Niche

Alice Cani, Carlotta Caterina Damanti, Federica Lovisa, Enrico Gaffo, Giulia Borile, Elisa Carraro, Pina Fusco, Elena Varotto, Stefania Bortoluzzi, Alessandra Biffi, Barbara Buldini, Carmelo Rizzari, Marta Pillon, Lara Mussolin, Silvia Bresolin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4081.
https://doi.org/10.1182/blood-2023-188680
Published: 2023
Journal Articles

Genetic Activation and Therapeutic Targeting of PIM1 in T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Renate De Smedt, MSc, Sofie Peirs, PhD, Julie Morscio, PhD, Juliette Roels, MSc, Steven Goossens, PhD, Aurore Touzart, MD, Anne Uyttebroeck, Nadine Van Roy, PhD, Tim Lammens, PhD, Lara Mussolin, PhD, Elizabeth Macyntire, MD PhD, Peter Vandenberghe, MD PhD, Pieter Van Vlierberghe, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1445.
https://doi.org/10.1182/blood.V130.Suppl_1.1445.1445
Published: 2017
Journal Articles

Elevated Level Expression of MiR-223 Is Associated with Worse Prognosis in Childhood T-Cell Lymphoblastic Lymphoma

Lara Mussolin, PhD, Elena Pomari, PhD, Marta Pillon, MD, Federica Lovisa, PhD, Elisa Carraro, PhD, Paolo Bonvini, PhD, Emanuele SG d'Amore, MD, Giuseppe Basso, MD
Journal: Blood
Blood (2016) 128 (22): 1098.
https://doi.org/10.1182/blood.V128.22.1098.1098
Published: 2016
Journal Articles

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK –positive anaplastic large-cell lymphoma

Clinical Trials & Observations Brief Report
Christine Damm-Welk, Lara Mussolin, Martin Zimmermann, Marta Pillon, Wolfram Klapper, Ilske Oschlies, Emanuele S. G. d’Amore, Alfred Reiter, Wilhelm Woessmann, Angelo Rosolen
Journal: Blood
Blood (2014) 123 (3): 334–337.
https://doi.org/10.1182/blood-2013-09-526202
Published: 2014
Includes: Supplemental data
Journal Articles

High Response Rates To Crizotinib In Advanced, Chemoresistant ALK+ Lymphoma Patients

Sara Redaelli, PhD, Francesca Farina, MD, Alessandra Stasia, MD, Monica Ceccon, PhD, Luca Mologni, PhD, Cristina Messa, MD, Luca Guerra, MD, Giovanni Giudici, MS, Elena Sala, MS, Lara Mussolin, PhD, Dries Deeren, MD, Michael H. King, MD, Michael Steurer, MD, Rainer Ordemann, MD, Amos Cohen, MD, Matthias Grube, MD, Lea Bernard, MD, Gianpaolo Chiriano, PhD, Rocco Piazza, MD, PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2013) 122 (21): 368.
https://doi.org/10.1182/blood.V122.21.368.368
Published: 2013
Journal Articles

Early Assessment of Minimal Residual Disease (MRD) by Qualitative PCR for NPM-ALK Identifies Patients At Very High Risk of Relapse in Anaplastic Large Cell Lymphoma

Christine Damm-Welk, PhD, Lara Mussolin, PhD, Marta Pillon, MD, Martin Zimmermann, PhD, Alfred Reiter, MD, Wilhelm Woessmann, MD, Angelo Rosolen, MD
Journal: Blood
Blood (2011) 118 (21): 1565.
https://doi.org/10.1182/blood.V118.21.1565.1565
Published: 2011
Journal Articles

Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150

Margherita Ghisi, Alberto Corradin, Katia Basso, Chiara Frasson, Valentina Serafin, Subhamoy Mukherjee, Lara Mussolin, Katia Ruggero, Laura Bonanno, Alessandro Guffanti, Gianluca De Bellis, Gino Gerosa, Giovanni Stellin, Donna M. D'Agostino, Giuseppe Basso, Vincenzo Bronte, Stefano Indraccolo, Alberto Amadori, Paola Zanovello
Journal: Blood
Blood (2011) 117 (26): 7053–7062.
https://doi.org/10.1182/blood-2010-12-326629
Published: 2011
Includes: Supplemental data
Journal Articles

Genomic and Transcriptomic Analyses Revealed Differences and Similarities Between T-Lbl and T-ALL .

Lara Mussolin, Katia Basso, PhD, Antonella Lettieri, Manisha Brahmachary, PhD, Giovanni Cazzaniga, Andrea Califano, PhD, Wei-Keat Lim, Giuseppe Basso, Andrea Biondi, Angelo Rosolen
Journal: Blood
Blood (2009) 114 (22): 2943.
https://doi.org/10.1182/blood.V114.22.2943.2943
Published: 2009
Journal Articles

Minimal Disseminated Disease Is An Independent Poor Prognosis Marker Among High Risk Burkitt's Lymphoma Patients .

Lara Mussolin, Marta Pillon, Gloria Tridello, Maria Paola Boaro, Emanuele S d'Amore, Luca Lo Nigro, Salvatore Buffardi, Alessandra Lombardi, Alessandra Sala, Claudio Favre, Maurizio Aricò, Angelo Rosolen
Journal: Blood
Blood (2009) 114 (22): 2944.
https://doi.org/10.1182/blood.V114.22.2944.2944
Published: 2009